{"id":21518,"date":"2018-12-13T17:03:53","date_gmt":"2018-12-13T16:03:53","guid":{"rendered":"https:\/\/www.anchormc.se\/?p=21518"},"modified":"2024-11-04T14:24:49","modified_gmt":"2024-11-04T13:24:49","slug":"pov-serialization-in-the-pharma-industry-part-2","status":"publish","type":"post","link":"https:\/\/www.anchormc.se\/en\/pov-serialization-in-the-pharma-industry-part-2\/","title":{"rendered":"Serialization In The Pharma Industry, part 2"},"content":{"rendered":"<p>The first challenge that I would like to address is who will take the additional<span class=\"apple-converted-space\">\u00a0<\/span><strong>Cost\u00a0<\/strong>for this? I did mention this already in the introduction part\u2026 There is no main rule here, so it will become a negotiation between the manufacturer and the other partners on how the additional cost will be distributed. However, it might mean that the manufacturer needs to raise their prices and there is a risk that the price is also adjusted, all the way to the consumer\/patient. This can be difficult as there might already be signed contracts in place. I think all parties need to look at how to make the information handling as efficient as possible, to keep the additional costs down. This can also develop into a competitive advantage.<\/p>\n<p>The next challenge is<span class=\"apple-converted-space\">\u00a0<\/span><strong>the handling\u00a0<\/strong>of the additional information that is required by the new regulations! With handling I mean<span class=\"apple-converted-space\">\u00a0<\/span><strong>create<\/strong>,<span class=\"apple-converted-space\">\u00a0<\/span><strong>send<\/strong>,<span class=\"apple-converted-space\">\u00a0<\/span><strong>receive<\/strong>,<span class=\"apple-converted-space\">\u00a0<\/span><strong>store\u00a0<\/strong>and<span class=\"apple-converted-space\">\u00a0<\/span><strong>trace\u00a0<\/strong>the information.<\/p>\n<p>To<span class=\"apple-converted-space\">\u00a0<\/span><strong>Create\u00a0<\/strong>means here both to reuse already existing information, but in many cases, it also means to create new information. One example is that each package of drugs needs to have a unique identity, consisting of a combination of the NDC (National Drug Code) and a running number. This unique identity must be printed on each package, but more about that later. There is also a need to have a solution that keeps track of which packages are put in the larger containers all the way up to the delivery level.<\/p>\n<p>As I said above, there is a need for more space to print more information on the package of the drug. This will imply that the labels need to be redesigned or even that a bigger package is needed.<\/p>\n<p>To<span class=\"apple-converted-space\">\u00a0<\/span><strong>Send\u00a0<\/strong>here means to first gather the information required by the regulation and then to create the documents where that must be used. That is the TI, TS and TH. The media for sending the information must be agreed in-between all involved parties that are involved in the information transfer. Each receiver needs to be able to<span class=\"apple-converted-space\">\u00a0<\/span><strong>Receive\u00a0<\/strong>these documents on this media. So, will the media be paper or any electronic format (like EDI or RFID). On top of this the information need to be<span class=\"apple-converted-space\">\u00a0<\/span><strong>Stored\u00a0<\/strong>for six years.<\/p>\n<p>To<span class=\"apple-converted-space\">\u00a0<\/span><strong>Trace\u00a0<\/strong>will then mean that the information needs to be accessible. This can result in very high amounts of information if the volume of transactions is high. But not only that, there are also a need to have a good architecture and good reports. So, to store this on paper format is not optimal. It of course requires a digital solution.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The first challenge that I would like to address is who will take the additional\u00a0Cost\u00a0for this? I did mention this already in the introduction part\u2026 There is no main rule here, so it will become a negotiation between the manufacturer and the other partners on how the additional cost will be distributed. However, it might [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false},"categories":[11,54,65],"tags":[],"class_list":["post-21518","post","type-post","status-publish","hentry","category-articles-en","category-business-development","category-life-science-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Serialization In The Pharma Industry, part 2 | Anchor Management Consulting<\/title>\n<meta name=\"description\" content=\"The first challenge that I would like to address is who will take the additional\u00a0Cost\u00a0for this? I did mention this already in the introduction part\u2026 There\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.anchormc.se\/en\/pov-serialization-in-the-pharma-industry-part-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Serialization In The Pharma Industry, part 2\" \/>\n<meta property=\"og:description\" content=\"The first challenge that I would like to address is who will take the additional\u00a0Cost\u00a0for this? I did mention this already in the introduction part\u2026 There\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.anchormc.se\/en\/pov-serialization-in-the-pharma-industry-part-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Anchor Management Consulting\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/anchormc.se\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-12-13T16:03:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-04T13:24:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.anchormc.se\/wp-content\/uploads\/Anchor-gruppbild-2023.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sven-Erik Andersson\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sven-Erik Andersson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.anchormc.se\/en\/pov-serialization-in-the-pharma-industry-part-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.anchormc.se\/en\/pov-serialization-in-the-pharma-industry-part-2\/\"},\"author\":{\"name\":\"Sven-Erik Andersson\",\"@id\":\"https:\/\/www.anchormc.se\/#\/schema\/person\/c97263bfd012ee1af302c8295d2d1e15\"},\"headline\":\"Serialization In The Pharma Industry, part 2\",\"datePublished\":\"2018-12-13T16:03:53+00:00\",\"dateModified\":\"2024-11-04T13:24:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.anchormc.se\/en\/pov-serialization-in-the-pharma-industry-part-2\/\"},\"wordCount\":448,\"publisher\":{\"@id\":\"https:\/\/www.anchormc.se\/#organization\"},\"articleSection\":[\"Articles\",\"Business development\",\"Life Science\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.anchormc.se\/en\/pov-serialization-in-the-pharma-industry-part-2\/\",\"url\":\"https:\/\/www.anchormc.se\/en\/pov-serialization-in-the-pharma-industry-part-2\/\",\"name\":\"Serialization In The Pharma Industry, part 2 | Anchor Management Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/www.anchormc.se\/#website\"},\"datePublished\":\"2018-12-13T16:03:53+00:00\",\"dateModified\":\"2024-11-04T13:24:49+00:00\",\"description\":\"The first challenge that I would like to address is who will take the additional\u00a0Cost\u00a0for this? I did mention this already in the introduction part\u2026 There\",\"breadcrumb\":{\"@id\":\"https:\/\/www.anchormc.se\/en\/pov-serialization-in-the-pharma-industry-part-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.anchormc.se\/en\/pov-serialization-in-the-pharma-industry-part-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.anchormc.se\/en\/pov-serialization-in-the-pharma-industry-part-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\/\/www.anchormc.se\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Serialization In The Pharma Industry, part 2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.anchormc.se\/#website\",\"url\":\"https:\/\/www.anchormc.se\/\",\"name\":\"Anchor Management Consulting\",\"description\":\"Vi hj\u00e4lper f\u00f6retag att bli framg\u00e5ngsrika\",\"publisher\":{\"@id\":\"https:\/\/www.anchormc.se\/#organization\"},\"alternateName\":\"Anchor\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.anchormc.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.anchormc.se\/#organization\",\"name\":\"Anchor Management Consulting\",\"alternateName\":\"Anchor\",\"url\":\"https:\/\/www.anchormc.se\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.anchormc.se\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.anchormc.se\/wp-content\/uploads\/anchor_mark_red_495.jpg\",\"contentUrl\":\"https:\/\/www.anchormc.se\/wp-content\/uploads\/anchor_mark_red_495.jpg\",\"width\":495,\"height\":498,\"caption\":\"Anchor Management Consulting\"},\"image\":{\"@id\":\"https:\/\/www.anchormc.se\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/anchormc.se\/\",\"https:\/\/www.instagram.com\/anchor_mc\/\",\"https:\/\/www.linkedin.com\/company\/anchormc\/\"],\"description\":\"V\u00e5r aff\u00e4rsid\u00e9 \u00e4r att driva aff\u00e4rs- och verksamhetsutveckling f\u00f6r kunder som vill ligga i framkant. F\u00f6retags utmaningar \u00e4r k\u00e4rnan i v\u00e5rt erbjudande och styr utvecklingen av v\u00e5r f\u00f6rm\u00e5ga.\",\"email\":\"hello@anchormc.se\",\"telephone\":\"+46 8 698 09 00\",\"legalName\":\"Anchor Managment Consulting AB\",\"foundingDate\":\"2007-06-01\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"11\",\"maxValue\":\"50\"},\"ethicsPolicy\":\"https:\/\/www.anchormc.se\/integritetspolicy\/\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.anchormc.se\/#\/schema\/person\/c97263bfd012ee1af302c8295d2d1e15\",\"name\":\"Sven-Erik Andersson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e69898962f89a38f90d093df62a64183025a961d66db4bd27213b91e09a29d57?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e69898962f89a38f90d093df62a64183025a961d66db4bd27213b91e09a29d57?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e69898962f89a38f90d093df62a64183025a961d66db4bd27213b91e09a29d57?s=96&d=mm&r=g\",\"caption\":\"Sven-Erik Andersson\"},\"description\":\"\u00bbJag arbetar huvudsakligen inom aff\u00e4rsprocessledning f\u00f6r logistik- och service-processer. Jag hj\u00e4lper v\u00e5ra kunder att f\u00f6rb\u00e4ttra deras aff\u00e4rsprocesser genom att st\u00f6tta hela v\u00e4gen fr\u00e5n utveckling av strategi, plannera f\u00f6r\u00e4ndringen, genomf\u00f6randet till att m\u00e4ta resultatet. Jag har jobbat med detta under 20 \u00e5rs tid och har mycket djup kunskap i ERP-systemet SAP.\u00ab\",\"url\":\"https:\/\/www.anchormc.se\/en\/author\/svenerikandersson\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Serialization In The Pharma Industry, part 2 | Anchor Management Consulting","description":"The first challenge that I would like to address is who will take the additional\u00a0Cost\u00a0for this? I did mention this already in the introduction part\u2026 There","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.anchormc.se\/en\/pov-serialization-in-the-pharma-industry-part-2\/","og_locale":"en_US","og_type":"article","og_title":"Serialization In The Pharma Industry, part 2","og_description":"The first challenge that I would like to address is who will take the additional\u00a0Cost\u00a0for this? I did mention this already in the introduction part\u2026 There","og_url":"https:\/\/www.anchormc.se\/en\/pov-serialization-in-the-pharma-industry-part-2\/","og_site_name":"Anchor Management Consulting","article_publisher":"https:\/\/www.facebook.com\/anchormc.se\/","article_published_time":"2018-12-13T16:03:53+00:00","article_modified_time":"2024-11-04T13:24:49+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/www.anchormc.se\/wp-content\/uploads\/Anchor-gruppbild-2023.jpeg","type":"image\/jpeg"}],"author":"Sven-Erik Andersson","twitter_misc":{"Written by":"Sven-Erik Andersson","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.anchormc.se\/en\/pov-serialization-in-the-pharma-industry-part-2\/#article","isPartOf":{"@id":"https:\/\/www.anchormc.se\/en\/pov-serialization-in-the-pharma-industry-part-2\/"},"author":{"name":"Sven-Erik Andersson","@id":"https:\/\/www.anchormc.se\/#\/schema\/person\/c97263bfd012ee1af302c8295d2d1e15"},"headline":"Serialization In The Pharma Industry, part 2","datePublished":"2018-12-13T16:03:53+00:00","dateModified":"2024-11-04T13:24:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.anchormc.se\/en\/pov-serialization-in-the-pharma-industry-part-2\/"},"wordCount":448,"publisher":{"@id":"https:\/\/www.anchormc.se\/#organization"},"articleSection":["Articles","Business development","Life Science"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.anchormc.se\/en\/pov-serialization-in-the-pharma-industry-part-2\/","url":"https:\/\/www.anchormc.se\/en\/pov-serialization-in-the-pharma-industry-part-2\/","name":"Serialization In The Pharma Industry, part 2 | Anchor Management Consulting","isPartOf":{"@id":"https:\/\/www.anchormc.se\/#website"},"datePublished":"2018-12-13T16:03:53+00:00","dateModified":"2024-11-04T13:24:49+00:00","description":"The first challenge that I would like to address is who will take the additional\u00a0Cost\u00a0for this? I did mention this already in the introduction part\u2026 There","breadcrumb":{"@id":"https:\/\/www.anchormc.se\/en\/pov-serialization-in-the-pharma-industry-part-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.anchormc.se\/en\/pov-serialization-in-the-pharma-industry-part-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.anchormc.se\/en\/pov-serialization-in-the-pharma-industry-part-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/www.anchormc.se\/en\/"},{"@type":"ListItem","position":2,"name":"Serialization In The Pharma Industry, part 2"}]},{"@type":"WebSite","@id":"https:\/\/www.anchormc.se\/#website","url":"https:\/\/www.anchormc.se\/","name":"Anchor Management Consulting","description":"Vi hj\u00e4lper f\u00f6retag att bli framg\u00e5ngsrika","publisher":{"@id":"https:\/\/www.anchormc.se\/#organization"},"alternateName":"Anchor","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.anchormc.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.anchormc.se\/#organization","name":"Anchor Management Consulting","alternateName":"Anchor","url":"https:\/\/www.anchormc.se\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anchormc.se\/#\/schema\/logo\/image\/","url":"https:\/\/www.anchormc.se\/wp-content\/uploads\/anchor_mark_red_495.jpg","contentUrl":"https:\/\/www.anchormc.se\/wp-content\/uploads\/anchor_mark_red_495.jpg","width":495,"height":498,"caption":"Anchor Management Consulting"},"image":{"@id":"https:\/\/www.anchormc.se\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/anchormc.se\/","https:\/\/www.instagram.com\/anchor_mc\/","https:\/\/www.linkedin.com\/company\/anchormc\/"],"description":"V\u00e5r aff\u00e4rsid\u00e9 \u00e4r att driva aff\u00e4rs- och verksamhetsutveckling f\u00f6r kunder som vill ligga i framkant. F\u00f6retags utmaningar \u00e4r k\u00e4rnan i v\u00e5rt erbjudande och styr utvecklingen av v\u00e5r f\u00f6rm\u00e5ga.","email":"hello@anchormc.se","telephone":"+46 8 698 09 00","legalName":"Anchor Managment Consulting AB","foundingDate":"2007-06-01","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"11","maxValue":"50"},"ethicsPolicy":"https:\/\/www.anchormc.se\/integritetspolicy\/"},{"@type":"Person","@id":"https:\/\/www.anchormc.se\/#\/schema\/person\/c97263bfd012ee1af302c8295d2d1e15","name":"Sven-Erik Andersson","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e69898962f89a38f90d093df62a64183025a961d66db4bd27213b91e09a29d57?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e69898962f89a38f90d093df62a64183025a961d66db4bd27213b91e09a29d57?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e69898962f89a38f90d093df62a64183025a961d66db4bd27213b91e09a29d57?s=96&d=mm&r=g","caption":"Sven-Erik Andersson"},"description":"\u00bbJag arbetar huvudsakligen inom aff\u00e4rsprocessledning f\u00f6r logistik- och service-processer. Jag hj\u00e4lper v\u00e5ra kunder att f\u00f6rb\u00e4ttra deras aff\u00e4rsprocesser genom att st\u00f6tta hela v\u00e4gen fr\u00e5n utveckling av strategi, plannera f\u00f6r\u00e4ndringen, genomf\u00f6randet till att m\u00e4ta resultatet. Jag har jobbat med detta under 20 \u00e5rs tid och har mycket djup kunskap i ERP-systemet SAP.\u00ab","url":"https:\/\/www.anchormc.se\/en\/author\/svenerikandersson\/"}]}},"_links":{"self":[{"href":"https:\/\/www.anchormc.se\/en\/wp-json\/wp\/v2\/posts\/21518","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.anchormc.se\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.anchormc.se\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.anchormc.se\/en\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.anchormc.se\/en\/wp-json\/wp\/v2\/comments?post=21518"}],"version-history":[{"count":3,"href":"https:\/\/www.anchormc.se\/en\/wp-json\/wp\/v2\/posts\/21518\/revisions"}],"predecessor-version":[{"id":24657,"href":"https:\/\/www.anchormc.se\/en\/wp-json\/wp\/v2\/posts\/21518\/revisions\/24657"}],"wp:attachment":[{"href":"https:\/\/www.anchormc.se\/en\/wp-json\/wp\/v2\/media?parent=21518"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.anchormc.se\/en\/wp-json\/wp\/v2\/categories?post=21518"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.anchormc.se\/en\/wp-json\/wp\/v2\/tags?post=21518"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}